TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16114985

Group type: EXPERIMENTAL
Intervention: Patient-specific vaccine (3 weekly injections of irradiated tumor cells)
Number of subjects: 156
Study: 12925626

Group type: EXPERIMENTAL
Intervention: Robotic-assisted implantation
Number of subjects: 154

Group type: COMPARATOR
Intervention: Manual implantation
Number of subjects: 154
Study: 10388499

Group type: EXPERIMENTAL
Intervention: UDCA
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 8905030

Group type: EXPERIMENTAL
Intervention: Bone Marrow Progenitor Cells (BMPC)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: BMPC & Peripheral Blood Progenitor Cells (PBPC)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Peripheral Blood Progenitor Cells (PBPC) alone
Number of subjects: 570
Study: 2002134

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Behavior therapy (BT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 57
Study: 6139119

Group type: EXPERIMENTAL
Intervention: Midazolam 12 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam 27 mg
Number of subjects: 0
Study: 29963892

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 108

Group type: COMPARATOR
Intervention: CPT or PE (combined results)
Number of subjects: 108
Study: 30545596

Group type: EXPERIMENTAL
Intervention: Swallowable gas-filled intragastric balloon system plus lifestyle therapy
Number of subjects: 387

Group type: COMPARATOR
Intervention: Lifestyle therapy alone
Number of subjects: 387
Study: 26821696

Group type: EXPERIMENTAL
Intervention: Epinephrine 0.05 µg kg(‐1) min(‐1) infusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline 0.9%)
Number of subjects: 100
Study: 24613294

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (6 soft-gel capsules of fish oil daily for 4 months)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (paraffin oil capsules)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 22273457

Group type: EXPERIMENTAL
Intervention: Intracoronary eptifibatide bolus only (Group A, n=67)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Intracoronary bolus and continuous intravenous infusion of eptifibatide (Group B, n=88)
Number of subjects: 155
Study: 19798503

Group type: EXPERIMENTAL
Intervention: PGB-monotherapy
Number of subjects: 1351

Group type: EXPERIMENTAL
Intervention: PGB add-on
Number of subjects: 1351

Group type: COMPARATOR
Intervention: Non-PGB drugs
Number of subjects: 1351
Study: 17123615

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation
Number of subjects: 210
Study: 15669555

Group type: EXPERIMENTAL
Intervention: Continuous combined hormone replacement therapy (HRT) with 2 mg estradiol valerate and 2 mg dienogest
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 12499617

Group type: EXPERIMENTAL
Intervention: Nicorandil cocktail (24 mg nicorandil, 5 mg nitroglycerin, 10,000 U heparin)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Verapamil cocktail (10 mg verapamil, 5 mg nitroglycerin, 10,000 U heparin)
Number of subjects: 61
Study: 10752844

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxygen
Number of subjects: 0
Study: 8991321

Group type: EXPERIMENTAL
Intervention: narrative elaboration intervention
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: instruction-based intervention
Number of subjects: 132

Group type: COMPARATOR
Intervention: control group
Number of subjects: 132
Study: 1479795

Group type: EXPERIMENTAL
Intervention: 150 mg tyrosine per kg body weight per day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3881838

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cimetidine (in patients where it failed)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ranitidine (in patients where it failed)
Number of subjects: 48
Study: 30291682

Group type: EXPERIMENTAL
Intervention: Topical application of cytidine (2%, 3%, and 4% w/w)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control formulation
Number of subjects: 0
Study: 29609720

Group type: EXPERIMENTAL
Intervention: Saline bolus of 22 mL/kg body weight
Number of subjects: 21

Group type: COMPARATOR
Intervention: Minimum rate saline infusion (control)
Number of subjects: 21
Study: 27442997

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24953909

Group type: EXPERIMENTAL
Intervention: Self etch adhesive (adhe SE one Ivoclar)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Total etch adhesive (Eco‐Etch Ivoclar)
Number of subjects: 70
Study: 22383098

Group type: EXPERIMENTAL
Intervention: 50 mg oral sildenafil
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 19747047

Group type: EXPERIMENTAL
Intervention: Presence of apolipoprotein E epsilon4 allele
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ICP-targeted therapy based on the Lund concept
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: GCS and ICP measurements
Number of subjects: 46
Study: 17410948

Group type: EXPERIMENTAL
Intervention: Mint Floss Pick
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard Rolled Floss
Number of subjects: 26
Study: 15694110

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 50 microg/24 h (Femseven)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Transdermal placebo
Number of subjects: 19
Study: 12400528

Group type: EXPERIMENTAL
Intervention: Tetravalent meningococcal polysaccharide vaccine conjugated to diphtheria at 1, 4, and 10 microg/ml dosages
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tetravalent meningococcal polysaccharide vaccine conjugated to diphtheria at 4 microg/ml
Number of subjects: 30
Study: 11783185

Group type: EXPERIMENTAL
Intervention: Runing Granule (RNG)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Tabellae Tamoxifen (Control)
Number of subjects: 187
Study: 7825538

Group type: EXPERIMENTAL
Intervention: Modified-fat diet (enzymatically modified palm oil)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Palm oil diet
Number of subjects: 60
Study: 2192497

Group type: EXPERIMENTAL
Intervention: Optical compliance
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amount of ventilation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Inflation pressure
Number of subjects: 30
Study: 31488289

Group type: EXPERIMENTAL
Intervention: T+S (0.5 mg testosterone and 50 mg sildenafil) under fed conditions
Number of subjects: 18

Group type: COMPARATOR
Intervention: T+S (0.5 mg testosterone and 50 mg sildenafil) under fasted conditions
Number of subjects: 18
Study: 29084632

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 833

Group type: COMPARATOR
Intervention: No Brief Intervention (no BI)
Number of subjects: 833
Study: 25682286

Group type: EXPERIMENTAL
Intervention: THP group (docetaxel, THP, cyclophosphamide)
Number of subjects: 48

Group type: COMPARATOR
Intervention: EPI group (docetaxel, EPI, cyclophosphamide)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: THP group
Number of subjects: 48

Group type: COMPARATOR
Intervention: EPI group
Number of subjects: 48
Study: 23772723

Group type: EXPERIMENTAL
Intervention: NP comanagement
Number of subjects: 485

Group type: COMPARATOR
Intervention: PCP care alone
Number of subjects: 485
Study: 21613745

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (inactive)
Number of subjects: 45
Study: 19419443

Group type: EXPERIMENTAL
Intervention: Adjunctive intra-muscular neridronate (12.5 mg injection/week for 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-surgical periodontal treatment (PT) only
Number of subjects: 60
Study: 16393441

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray (0.2 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Desloratadine tablets (5 mg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 15280773

Group type: EXPERIMENTAL
Intervention: HIV-1 subtype C env (C-env)
Number of subjects: 253

Group type: COMPARATOR
Intervention: HIV-1 subtype A env (A-env)
Number of subjects: 253

Group type: COMPARATOR
Intervention: HIV-1 subtype D env (D-env)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Combined subtypes A env and D env
Number of subjects: 253
Study: 11226744

Group type: EXPERIMENTAL
Intervention: 3mg MEL
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9215017

Group type: COMPARATOR
Intervention: Hyaluronidase 300 iu ml‐1
Number of subjects: 200

Group type: COMPARATOR
Intervention: Hyaluronidase 50 iu ml‐1
Number of subjects: 200
Study: 7535064

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: All treatment groups (high-dose, low-dose, placebo)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Aprotinin (high and low doses)
Number of subjects: 165
Study: 3555584

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg + HCTZ 12.5 mg (25/12.5)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg + HCTZ 25 mg (50/25)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Captopril 100 mg + HCTZ 50 mg (100/50)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 30145148

Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine (FU)/bevacizumab (Bev)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Bevacizumab (Bev)
Number of subjects: 471

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: BRAF mutation
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: RAS mutation
Number of subjects: 471
Study: 26480205

Group type: COMPARATOR
Intervention: Telephone-administered psychotherapy (T-P)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Telephone-administered social rhythm therapy (T-SRT)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Telephone-administered intensive clinical management (T-ICM)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 221
Study: 24286379

Group type: EXPERIMENTAL
Intervention: Smoking cessation (3 months)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Non-quitters
Number of subjects: 46
Study: 22438325

Group type: EXPERIMENTAL
Intervention: Leukoreduced transfusions
Number of subjects: 489

Group type: COMPARATOR
Intervention: Nonleukoreduced transfusions
Number of subjects: 489
Study: 20434604

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) system for 3 months, activating during walking for 6 to 8 hours/day, 7 days/week, plus walking 1 hour/day, 6 days/week
Number of subjects: 28

Group type: COMPARATOR
Intervention: Walking 1 hour/day, 6 days/week without FES
Number of subjects: 28
Study: 18164460

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonsurgical interventions
Number of subjects: 0
Study: 15871591

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 0
Study: 12952838

Group type: EXPERIMENTAL
Intervention: HCM patients
Number of subjects: 36

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 36
Study: 9892124

Group type: EXPERIMENTAL
Intervention: Modified flexible suture implant
Number of subjects: 2

Group type: COMPARATOR
Intervention: Tricortical screw
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both interventions at 5.0 cm
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both interventions at 2.0 cm
Number of subjects: 2
Study: 8545491

Group type: EXPERIMENTAL
Intervention: Lower-extremity ergometer test (LE test)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Arm-cranking ergometer test (AC test)
Number of subjects: 15
Study: 1839585

Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg b.i.d.)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6356556

Group type: EXPERIMENTAL
Intervention: Adriamycin instillation at 1 week intervals followed by 6 instillations at 2 weeks intervals and then 8 instillations at 4 weeks intervals.
Number of subjects: 411

Group type: COMPARATOR
Intervention: Adriamycin instillation at intervals of 1, 2, and 4 weeks (first study).
Number of subjects: 411
Study: 31866929

Group type: EXPERIMENTAL
Intervention: eCBT‐I (automated Internet‐delivered cognitive behavioral therapy for insomnia)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: eCBT‐I
Number of subjects: 46

Group type: COMPARATOR
Intervention: mPT (minimal psychoeducation therapy)
Number of subjects: 46

Group type: COMPARATOR
Intervention: eCBT‐I and mPT
Number of subjects: 46
Study: 28460127

Group type: EXPERIMENTAL
Intervention: Anodal tDCS plus a brief cognitive intervention (BCI)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Anodal tDCS plus pain education
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS plus BCI
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS plus pain education
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Sham tDCS plus BCI
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sham tDCS plus pain education
Number of subjects: 79
Study: 26638161

Group type: COMPARATOR
Intervention: SoluMatrix meloxicam 10 mg (fasting)
Number of subjects: 28

Group type: COMPARATOR
Intervention: meloxicam 15 mg tablets (fasting)
Number of subjects: 28

Group type: COMPARATOR
Intervention: SoluMatrix meloxicam 5 mg (fasting)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SoluMatrix meloxicam 10 mg
Number of subjects: 28
Study: 24673713

Group type: EXPERIMENTAL
Intervention: Tac (n=21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: CsA (n=21)
Number of subjects: 42
Study: 22803939

Group type: EXPERIMENTAL
Intervention: Person‐Based Cognitive Therapy (PBCT) plus Treatment as Usual (TAU)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 28
Study: 20934698

Group type: EXPERIMENTAL
Intervention: Double-bundle ACL reconstruction technique (ST/G)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-bundle ACL reconstruction technique (BPTB)
Number of subjects: 0
Study: 17637192

Group type: EXPERIMENTAL
Intervention: Fast release formulation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Slow release formulation
Number of subjects: 18
Study: 15935625

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS of right DLPFCx
Number of subjects: 180
Study: 12180532

Group type: EXPERIMENTAL
Intervention: AERx pulmonary delivery system with ABT-431 (1, 2, 4, and 8 mg doses)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: AERx pulmonary delivery system with ABT-431
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intravenous infusion of ABT-431 (5 mg over 1 hr)
Number of subjects: 9
Study: 10343980

Group type: EXPERIMENTAL
Intervention: Intravenous propranolol (2 mg every 4 hours until delivery)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no propranolol)
Number of subjects: 57
Study: 7532572

Group type: EXPERIMENTAL
Intervention: Visual and auditory stimuli presented in separate blocks (exp. 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual and auditory stimuli presented together (exp. 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimuli preceded by stimuli at the contralateral side
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preceding stimulus at a to‐be‐attended location
Number of subjects: 0
Study: 1944468

Group type: EXPERIMENTAL
Intervention: Prolonged administration of epipodophyllotoxin (teniposide with or without etoposide) twice weekly or weekly
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Epipodophyllotoxins (any schedule)
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Epipodophyllotoxins administered twice weekly
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Epipodophyllotoxins administered weekly
Number of subjects: 734

Group type: COMPARATOR
Intervention: No epipodophyllotoxins or treated only during remission induction or every two weeks during continuation treatment
Number of subjects: 734
Study: 6750780

Group type: EXPERIMENTAL
Intervention: 600 mg penicillamine daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: 300 mg penicillamine daily
Number of subjects: 100
Study: 30001465

Group type: EXPERIMENTAL
Intervention: Diabetes-specific enteral formula (DSF)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 104
Study: 28536868

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1 body mass)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 26316729

Group type: EXPERIMENTAL
Intervention: Virtual reality video game dancing (DANCE)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Treadmill walking with simultaneous verbal memory training (MEMORY)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Treadmill walking (PHYS)
Number of subjects: 89
Study: 23975885

Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg twice daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 21085035

Group type: EXPERIMENTAL
Intervention: Arm constant work rate (CWR) ergometry
Number of subjects: 13

Group type: COMPARATOR
Intervention: Leg constant work rate (CWR) ergometry
Number of subjects: 13
Study: 18335179

Group type: EXPERIMENTAL
Intervention: MRCT
Number of subjects: 1511
Study: 16565873

Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis
Number of subjects: 306

Group type: COMPARATOR
Intervention: Ureteral reimplantation
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 306

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Overall management (medical or surgical)
Number of subjects: 306
Study: 14725384

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 2% zinc citrate/0.3% Triclosan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoride toothpaste
Number of subjects: 0
Study: 11094553

Group type: EXPERIMENTAL
Intervention: Invasive treatment (PTCA or CABG)
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 1008
Study: 9297732

Group type: EXPERIMENTAL
Intervention: Dialysis with a polyacrylonitril parallel membrane (AN‐69)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dialysis with a cellulose‐acetate hollow fiber membrane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vancomycin intravenous loading dosage
Number of subjects: 12
Study: 8267686

Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic discectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Microdiscectomy
Number of subjects: 40
Study: 3535661

Group type: EXPERIMENTAL
Intervention: Piperacillin (18 g/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Cefoxitin (12 g/day)
Number of subjects: 70
Study: 31563894

Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalimumab (ADA)
Number of subjects: 0
Study: 29802852

Group type: EXPERIMENTAL
Intervention: Curcumin (1,500 mg orally, twice per day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (identical-appearing capsules)
Number of subjects: 44
Study: 27487408

Group type: EXPERIMENTAL
Intervention: Live educational music therapy
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Recorded educational music therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Education without music
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Recreational music therapy
Number of subjects: 130
Study: 25831695

Group type: EXPERIMENTAL
Intervention: Combined anesthesia (CA) with thoracic epidural analgesia using ropivacaine 0.3%, fentanyl 4 µg/ml, and epinephrine 2 µg/ml, followed by epidural infusion of ropivacaine 0.2%, fentanyl 2 µg/ml, and epinephrine 2 µg/ml for 5-7 days post-surgery.
Number of subjects: 472

Group type: COMPARATOR
Intervention: General anesthesia (GA) with fentanyl, ketamine, propofol, sevoflurane, and intercostal blockade with a mixture of alcohol and novocaine.
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Combined anesthesia (CA) for lobectomy patients.
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Combined anesthesia (CA) for pneumonectomy patients.
Number of subjects: 472

Group type: COMPARATOR
Intervention: General anesthesia (GA) for lobectomy patients.
Number of subjects: 472

Group type: COMPARATOR
Intervention: General anesthesia (GA) for pneumonectomy patients.
Number of subjects: 472
Study: 23425955

Group type: EXPERIMENTAL
Intervention: T40/A5 FDC therapy (telmisartan 40 mg + amlodipine 5 mg)
Number of subjects: 44
Study: 21915542

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery
Number of subjects: 107

Group type: COMPARATOR
Intervention: Extramedullary guide
Number of subjects: 107

Group type: COMPARATOR
Intervention: Intramedullary guide
Number of subjects: 107
Study: 18564326

Group type: EXPERIMENTAL
Intervention: Recombinant Bet v 1 trimer
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Equimolar mixture of two recombinant Bet v 1 fragments
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 124
Study: 17234070

Group type: EXPERIMENTAL
Intervention: Computer-based self-directed learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Didactic lecture-style learning
Number of subjects: 0
Study: 12800102

Group type: EXPERIMENTAL
Intervention: Running (treadmill test)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cycling (cycle ergometer test)
Number of subjects: 12